Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
IBRX holding history
ImmunityBio, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q1 2025 holdings
- Shares (Q1 2025)
- 737
- Value
- $2.22K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 737 | $2.22K | <0.1% | −263−26.3% | Reduced | Holders |
| Q4 2024 | 1,000 | $2.56K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,000 | $3.72K | <0.1% | +1,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q4 2022 | 1,000 | $5.07K | <0.1% | +1,000 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q1 2022 | 1,000 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,000 | $6.00K | <0.1% | +1,000 | New | Holders |